Zogenix Inc
NASDAQ:ZGNX 3:59:46 PM EDT
| Market Cap (Intraday) | 1.05B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $19.27 |
| 50-Day MA | $20.62 |
| 200-Day MA | $21.66 |
Zogenix, Inc. Stock, NASDAQ:ZGNX
5959 Horton Street, 5th floor, Emeryville, California 94608
United States of America
Phone: +1.858.259.1165
Number of Employees: 141
Description
Zogenix, Inc. is a pharmaceutical company. It engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include ZX008 and Relday. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA.